The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

From Brede Wiki
Jump to: navigation, search
Paper (help)
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
Authors: A. van Hylckama Vlieg, F. M. Helmerhorst, J. P. Vandenbroucke, C. J. M. Doggen, F. R. Rosendaal
Citation: BMJ (Clinical research ed.) 339 : b2921. 2009
Database(s): PubMed (PMID/19679614)
DOI: 10.1136/bmj.b2921.
PMCID:2726929
Link(s):
Search
Web: Bing Google Yahoo!Google PDF
Article: BASE Google Scholar PubMed
Restricted: DTU Digital Library
Other: NIF
Services
Format: BibTeX Template from PMID
Extract:

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study is a study on oral contraceptives and venous thromboembolism. Several types of oral contraceptives are compared to non-use.

The study was together with a parallel paper, Hormonal contraception and risk of venous thromboembolism: national follow-up study, described in an Editorial by Nick Dunn.[1] The study was mentioned in Danish mainstream media.[2]

[edit] Related papers

  1. Hormonal contraception and risk of venous thromboembolism: national follow-up study

[edit] See also

  1. Drospirenone and venous thromboembolism

[edit] References

  1. Nick Dunn (2009). "Oral contraceptives and venous thromboembolism". BMJ missing volume: missing pages.
  2. Danskere snydes for 'sunde' p-piller
Personal tools